Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Research & Development: 2013-2024

Historic Research & Development for Soleno Therapeutics (SLNO) over the last 9 years, with Dec 2024 value amounting to $78.6 million.

  • Soleno Therapeutics' Research & Development rose 255.03% to $1.0 million in Q4 2017 from the same period last year, while for Dec 2017 it was $3.1 million, marking a year-over-year decrease of 10.42%. This contributed to the annual value of $78.6 million for FY2024, which is 211.91% up from last year.
  • According to the latest figures from FY2024, Soleno Therapeutics' Research & Development is $78.6 million, which was up 211.91% from $25.2 million recorded in FY2023.
  • In the past 5 years, Soleno Therapeutics' Research & Development registered a high of $78.6 million during FY2024, and its lowest value of $15.3 million during FY2022.
  • For the 3-year period, Soleno Therapeutics' Research & Development averaged around $39.7 million, with its median value being $25.2 million (2023).
  • Data for Soleno Therapeutics' Research & Development shows a peak YoY skyrocketed of 211.91% (in 2024) over the last 5 years.
  • Soleno Therapeutics' Research & Development (Yearly) stood at $15.3 million in 2022, then skyrocketed by 65.01% to $25.2 million in 2023, then skyrocketed by 211.91% to $78.6 million in 2024.